Netoglitazone

VEGF-A121 is one of five isoforms (121, 145, 165, 189, and 206) of VEGF protein, a cytokine belonging to the Platelet Differentiation Growth Factor (PDGF) family, and existing as a disulfide-linked homodimeric glycoprotein. In contrast to the longer

Vascular Endothelial Growth Factor (VEGF) is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability.

Vascular Endothelial Growth Factor (VEGF) was initially purified from media conditioned by normal bovine pituitary folliculo-stellate cells and by a variety of transformed cell lines as a mitogen specific for vascular endothelial cells. It was

Biochem/physiol Actions Volasertib (BI 6727) is an orally active, ATP-competitive, potent and selective polo-like kinase (PLK) inhibitor (PLK1/2/3 IC50 = 0.87/5/56 nM by kinase assay with 7.

Biochem/physiol Actions Volasertib (BI 6727) is an orally active, ATP-competitive, potent and selective polo-like kinase (PLK) inhibitor (PLK1/2/3 IC50 = 0.87/5/56 nM by kinase assay with 7.

A competitive antagonist of S1P1 and S1P3 receptors (pKis = 7.86 and 5.93, respectively) inhibits S1P-induced migration of thyroid cancer cells, ovarian cancer cells, and neural stem cells.

VU6012962 is an orally bioavailable and CNS-penetrant metabotropic glutamate receptor 7 negative allosteric modulator ( mGlu 7 NAM) with an IC 50 of 347 nMIn VitroVU6012962 is highly selective for mGlu7 versus the other seven mGlu receptor subtypes.

VU6012962 is an orally bioavailable and CNS-penetrant metabotropic glutamate receptor 7 negative allosteric modulator ( mGlu 7 NAM) with an IC 50 of 347 nMIn VitroVU6012962 is highly selective for mGlu7 versus the other seven mGlu receptor subtypes.

VU6012962 is an orally bioavailable and CNS-penetrant metabotropic glutamate receptor 7 negative allosteric modulator ( mGlu 7 NAM) with an IC 50 of 347 nMIn VitroVU6012962 is highly selective for mGlu7 versus the other seven mGlu receptor subtypes.

VU6012962 is an orally bioavailable and CNS-penetrant metabotropic glutamate receptor 7 negative allosteric modulator ( mGlu 7 NAM) with an IC 50 of 347 nMIn VitroVU6012962 is highly selective for mGlu7 versus the other seven mGlu receptor subtypes.

VU6012962 is an orally bioavailable and CNS-penetrant metabotropic glutamate receptor 7 negative allosteric modulator ( mGlu 7 NAM) with an IC 50 of 347 nMIn VitroVU6012962 is highly selective for mGlu7 versus the other seven mGlu receptor subtypes.

VX 702 is an ATP-competitive inhibitor of p38α and p38β MAPK.